| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,148,871 | 1,173,560 | 1,160,284 | 1,171,134 | | Cost of Revenue | 295,812 | 290,711 | 285,208 | 300,330 | | | Gross Profit | 853,059 | 882,849 | 875,076 | 870,804 | | | Operating Expenses | | Research Development | 206,925 | 358,430 | 305,242 | 381,861 | | Selling General and Administrative | 317,961 | 341,329 | 331,170 | 347,305 | | Non Recurring |
-
| 2,036 |
-
|
-
| | Others | 57,598 | 59,884 | 55,295 | 55,605 | | | | Total Operating Expenses |
-
| 761,679 |
-
|
-
| | | | Operating Income or Loss | 270,575 | 121,170 | 183,369 | 86,033 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,795 | 11,085 | (3,035) | 22,524 | | Earnings Before Interest And Taxes | 274,370 | 132,893 | 180,900 | 109,120 | | Interest Expense |
-
| 822 | 792 | 1,149 | | Income Before Tax | 274,370 | 132,071 | 180,108 | 107,971 | | Income Tax Expense | 78,884 | 45,421 | 60,512 | 38,407 | | Minority Interest |
-
| 625 | 566 | 563 | | | | Net Income From Continuing Ops | 195,486 | 86,650 | 119,596 | 69,564 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 195,486 | 86,650 | 119,596 | 69,564 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $195,486 | $86,650 | $119,596 | $69,564 |
|
0.45% Nasdaq 
0.20%
Income Statement
